GoodRx (NASDAQ:GDRX – Get Rating) had its target price cut by stock analysts at SVB Leerink from $49.00 to $33.00 in a note issued to investors on Tuesday, The Fly reports. SVB Leerink’s target price would indicate a potential upside of 94.00% from the company’s previous close. Several other research firms also recently commented on […]